Peptide record

TPDB08073

Antibacterial Anticancer Antifungal Antiviral Toxicity standard
15 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB08073
Antibacterial Anticancer Antifungal Antiviral Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP pep-lab Peptipedia AntiCP 2.0 CancerPPD 2.0 SATPdb dbACP iACP-DRLF Antifungipept CAFPdb AI4AVP
standard
No
A 15-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
FKCRRWQWRMKKLGA
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C91H144N30O17S2
NDEHIPSTYV
RK
1994.46
12.14
6
0
6
+6
3.20
-1.207
32.67
Mammalian: 1.1 hour Yeast: 3 min E.coli: 2 min
11000
5.52
2
Residue Composition
number
1
A
3
R
0
N
0
D
1
C
0
E
1
Q
1
G
0
H
0
I
1
L
3
K
1
M
1
F
0
P
0
S
0
T
2
W
0
Y
0
V
Amino Acid Distribution
A: 1 R: 3 N: 0 D: 0 C: 1 E: 0 Q: 1 G: 1 H: 0 I: 0 L: 1 K: 3 M: 1 F: 1 P: 0 S: 0 T: 0 W: 2 Y: 0 V: 0
Chemical Descriptors
15 reviewed residue count
C91H144N30O17S2 sequence-only estimate (linear, free termini)
1994.46 sequence-only estimate (linear, free termini)
12.14 sequence-only estimate (linear, free termini)
+6 sequence-only estimate (linear, free termini)
3.20 sequence-only estimate (linear, free termini)
-1.207 sequence-only estimate (linear, free termini)
Evidence Records 3 records
Evidence 1 Activity

Activity

5% Hemolysis
Toxicity
64 µg/mL
Hemolytic Cytotoxic
5% Hemolysis | 64 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Comparative antimicrobial activity and mechanism of action of bovine lactoferricin-derived synthetic peptides. | Biometals | 2011
Evidence 2 Activity

Activity

8% Hemolysis
Toxicity
256 µg/mL
Hemolytic Cytotoxic
8% Hemolysis | 256 | µg/mL | target cell: Mouse erythrocytes

Target

Mouse erythrocytes

Source & Reference

NA
DBAASP
Killing of Staphylococcus aureus and Salmonella enteritidis and neutralization of lipopolysaccharide by 17-residue bovine lactoferricins: improved activity of Trp/Ala-containing molecules. | Sci Rep | 2017
Evidence 3 Activity

Activity

7.9% Hemolysis
Toxicity
12.5 µM
Hemolytic Cytotoxic
7.9% Hemolysis | 12.5 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Effect of Polyvalence on the Antibacterial Activity of a Synthetic Peptide Derived from Bovine Lactoferricin against Healthcare-Associated Infectious Pathogens. | Biomed Res Int | 2018